The senescence-associated secretory phenotype (SASP) is responsible for the deleterious effects of senescent cells in ageing and cancer. A new study shows that NAD+ metabolism can regulate the pro-inflammatory SASP, thereby promoting tumorigenesis.
References
Herranz, N. & Gil, J. J. Clin. Invest. 128, 1238–1246 (2018).
Georgilis, A. et al. Cancer Cell 34, 85–102.e109 (2018).
Nacarelli, T. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-019-0287-4 (2019).
Narita, M. et al. Cell 126, 503–514 (2006).
Garten, A. et al. Nat. Rev. Endocrinol. 11, 535–546 (2015).
Rielland, M. et al. J. Clin. Invest. 124, 2125–2135 (2014).
Kaplon, J. et al. Nature 498, 109–112 (2013).
Rajman, L., Chwalek, K. & Sinclair, D. A. Cell Metab. 27, 529–547 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.G. owns equity in and is a consultant for Unity Biotechnology. Unity Biotechnology funds research on senolytics in the laboratory of J.G. J.G is a named inventor in a filed MRC patent related to senolytic therapies (PCT/GB2018/051437) that has been licensed to Unity Biotechnology.
Rights and permissions
About this article
Cite this article
Søgaard, P.P., Gil, J. NAD+: a metabolic knob fine-tuning inflammation during senescence. Nat Metab 1, 310–311 (2019). https://doi.org/10.1038/s42255-019-0047-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-019-0047-6
- Springer Nature Limited